TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Ascensia Diabetes Care Norway AS
Closing information (x1000 EUR)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
10,181
|
9,463
|
8,579 |
| Financial expenses |
2
|
4
|
19 |
| Earnings before taxes |
733
|
573
|
309 |
| Total assets |
4,854
|
4,419
|
5,112 |
| Current assets |
4,744
|
4,344
|
5,015 |
| Current liabilities |
3,220
|
2,712
|
2,258 |
| Equity capital |
1,249
|
1,653
|
2,809 |
| - share capital |
9
|
9
|
9 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
25.7%
|
37.4%
|
54.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
6.1%
|
3.6% |
| Return on assets (ROA) |
15.1%
|
13.1%
|
6.4% |
| Current ratio |
147.3%
|
160.2%
|
222.1% |
| Return on equity (ROE) |
58.7%
|
34.7%
|
11.0% |
| Change turnover |
481
|
1,157
|
97 |
| Change turnover % |
5%
|
14%
|
1% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.